chevron_leftBack
As of 13 June 2026, Evoke Pharma, Inc. has a market cap of $23.72M USD, ranking #35876 globally and #4908 in the United States.
It ranks #3222 in the Healthcare sector, and #194 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$23.72MUSD
Enterprise Value
$17.26MUSD
Revenue (TTM)
$14.42MUSD
Net Income (TTM)
-$5.23MUSD
Profit Margin
-36%
Forward PE
275.0
PS Ratio
2.1
PB Ratio
7.1
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Matthew D'Onofrio
open_in_new
Employees
3
Founded
2007
IPO
25 Sep 2013
Website
evokepharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 0.6% | 2.9% | 117% | 280% | 134% |
News
Loading...
EVOK Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
EVOK
Evoke Pharma Inc
ISIN: US30049G3020
Shares Out.:
Shares Outstanding:
1.722M1
Shares Float:
1.487M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
11.00 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Evoke Pharma, Inc.
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
125K%
|
-
|
|
LSE: INDV
|
$2.07B
9K%
1.54B GBP
|
-
|
|
OTCMKTS: NDOI
|
$1.8B
7K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
7K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
5K%
|
-
|
|
NYSE: BRBR
|
$1.02B
4K%
|
12.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.75B
155K%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.84B
67K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
47K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
46K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
38K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.74B
37K%
7.57B EUR
|
-
|
chevron_leftBack